XORTX Therapeutics Inc. (XRTX)
NASDAQ
XRTX price, last 12 months
Key stats
- Previous close
- $1.06
- Open
- $1.01
- Day range
- $0.8668 – $1.06
- 52-week range
- $0.8101 – $3.60
- Volume
- 51.3K
- Avg volume (20 days)
- 186.5K
- Market cap
- $2.0M
Performance
Technicals and fundamentals
About XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
- Listed on
- NASDAQ
- Market cap
- $2.0M